Close Menu

LGC

In addition to licensing patents to DuPont, Biosearch will manufacture Scorpions primer oligonucleotides for DuPont's use in food diagnostics.

The Applied Research and Technology Development Award is the single largest amount of non-dilutive funding received by Micronics to date and will help the company add to the menu of tests under development for PanNAT, the company's portable system for nucleic acid amplification-based point-of-care testing.

Biosearch has licensed to Seegene patents covering its CAL Fluor and Quasar fluorophores and BHQ dark quencher dye; and will manufacture research- and in vitro diagnostic-grade oligonucleotides for Seegene.

The Korean molecular diagnostics firm has licensed patents covering Biosearch's BHQ, CAL Fluor, and Quasar technologies.

Last month the company won a similar award from DoD to develop qPCR-based assays for arbovirus pathogens.

The $750,000 grant from DoD will fund development of assays and analytes for PCR tests for rickettsial pathogens.

The firm will use the $800,000 grant to develop assays for pathogens prioritized by DoD and NIAID.

The cross-licensing agreement covers Qiagen's Scorpions technology and Biosearch's Black Hole Quencher dyes.

Biosearch can now manufacture, catalogue, and sell Scorpions primer assays into the research, applied, and infectious disease testing markets; while Qiagen receives worldwide rights to market labeled probes based on Biosearch's Black Hole Quencher dyes for qPCR assays in all applied testing and in vitro diagnostic fields.

Under the deal, Biosearch has the exclusive rights to manufacture, catalogue, and sell validated RNA FISH probes, assays, and kits in the research, applied markets, and in vitro diagnostic fields.

Pages

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.